Suppr超能文献

酶清创术联合胶原酶治疗创面和溃疡:系统评价和荟萃分析。

Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis.

机构信息

Family Medicine and Emergency Medicine Department, Faculty of Medicine, Université Laval, Québec, Canada.

Complex Wound Care Clinic and Hyperbaric Unit, Centre Hospitalier Affilié Universitaire Hôtel-Dieu de Lévis, Lévis, Canada.

出版信息

Int Wound J. 2017 Dec;14(6):1055-1065. doi: 10.1111/iwj.12760. Epub 2017 Apr 25.

Abstract

Enzymatic debridement with collagenase is a technique that is commonly used in clinical practice. This systematic review examines the effect of collagenase on all kinds of wounds, compared to an alternative therapy, on wound healing, wound bed characteristics, cost-effectiveness and the occurrence of adverse events. We conducted a systematic literature search on available literature in Cochrane databases, MEDLINE, EMBASE and CINAHL. Two investigators independently assessed the titles and abstracts of all randomised controlled trials obtained involving collagenase of all kinds of wounds based on inclusion criteria. Of the 1411 citations retrieved, 22 studies reported outcomes with the use of collagenase either for wound healing or wound debridement. Results support the use of collagenase for enzymatic debridement in pressure ulcers, diabetic foot ulcers and in conjunction with topical antibiotics for burns. However, studies presented a high risk of bias. Risk ratio of developing an adverse event related to collagenase versus the alternative treatment was statistically significant (for 10 studies, RR: 1·79, 95% CI 1·24-2·59, I =0%, P = 0·002). There is very limited data on the effect of collagenase as an enzymatic debridement technique on wounds. More independant research and adequate reporting of adverse events are warranted.

摘要

胶原酶酶清创术是一种在临床实践中常用的技术。本系统评价考察了胶原酶在各种伤口中的应用效果,与替代疗法相比,在伤口愈合、伤口床特征、成本效益和不良事件发生方面的效果。我们在 Cochrane 数据库、MEDLINE、EMBASE 和 CINAHL 中对现有文献进行了系统的文献检索。两名研究者根据纳入标准,独立评估了从所有涉及各种伤口胶原酶的随机对照试验中获得的标题和摘要。在检索到的 1411 条引用中,有 22 项研究报告了使用胶原酶在压疮、糖尿病足溃疡以及与局部抗生素联合治疗烧伤方面的结果。结果支持将胶原酶用于压力性溃疡、糖尿病足溃疡的酶清创,以及与局部抗生素联合使用。然而,这些研究存在较高的偏倚风险。与替代治疗相比,与胶原酶相关的不良事件的风险比具有统计学意义(10 项研究,RR:1.79,95%CI 1.24-2.59,I =0%,P =0.002)。关于胶原酶作为一种酶清创技术对伤口影响的证据非常有限。需要进行更多独立的研究,并充分报告不良事件。

相似文献

1
Enzymatic debridement with collagenase in wounds and ulcers: a systematic review and meta-analysis.
Int Wound J. 2017 Dec;14(6):1055-1065. doi: 10.1111/iwj.12760. Epub 2017 Apr 25.
2
Topical antimicrobial agents for treating foot ulcers in people with diabetes.
Cochrane Database Syst Rev. 2017 Jun 14;6(6):CD011038. doi: 10.1002/14651858.CD011038.pub2.
3
Dressings and topical agents for treating pressure ulcers.
Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD011947. doi: 10.1002/14651858.CD011947.pub2.
4
Antiseptics for burns.
Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD011821. doi: 10.1002/14651858.CD011821.pub2.
5
Enzymatic wound debridement.
J Wound Ostomy Continence Nurs. 2008 May-Jun;35(3):273-80. doi: 10.1097/01.WON.0000319125.21854.78.
6
Foam dressings for treating pressure ulcers.
Cochrane Database Syst Rev. 2017 Oct 12;10(10):CD011332. doi: 10.1002/14651858.CD011332.pub2.
7
Anabolic steroids for treating pressure ulcers.
Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011375. doi: 10.1002/14651858.CD011375.pub2.
8
Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes.
Cochrane Database Syst Rev. 2021 Feb 8;2(2):CD012835. doi: 10.1002/14651858.CD012835.pub2.
9
Beds, overlays and mattresses for preventing and treating pressure ulcers: an overview of Cochrane Reviews and network meta-analysis.
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD013761. doi: 10.1002/14651858.CD013761.pub2.
10
Topical phenytoin for treating pressure ulcers.
Cochrane Database Syst Rev. 2017 Feb 22;2(2):CD008251. doi: 10.1002/14651858.CD008251.pub2.

引用本文的文献

1
What's New in Wound Healing: Treatment Advances and Microbial Insights.
Am J Clin Dermatol. 2025 Jun 11. doi: 10.1007/s40257-025-00953-9.
3
Biofilm Dispersal and Wound Infection Clearance With Preclinical Debridement Agents.
Int Wound J. 2025 Mar;22(3):e70145. doi: 10.1111/iwj.70145.
4
Pressure injuries and biofilms: Microbiome, model systems and therapies.
Wound Repair Regen. 2025 Jan-Feb;33(1):e70005. doi: 10.1111/wrr.70005.
6
Hydrogel-Based Oxygen and Drug Delivery Dressing for Improved Wound Healing.
ACS Omega. 2024 May 22;9(22):24095-24104. doi: 10.1021/acsomega.4c03324. eCollection 2024 Jun 4.
7
A conserved strategy to attack collagen: The activator domain in bacterial collagenases unwinds triple-helical collagen.
Proc Natl Acad Sci U S A. 2024 Apr 16;121(16):e2321002121. doi: 10.1073/pnas.2321002121. Epub 2024 Apr 9.
8
ICG-mediated fluorescence-assisted debridement to promote wound healing.
PLoS One. 2023 Sep 21;18(9):e0291508. doi: 10.1371/journal.pone.0291508. eCollection 2023.
9
In Vitro Study of a Novel -Based Collagenase for Future Medical Application.
Cells. 2023 Aug 8;12(16):2025. doi: 10.3390/cells12162025.

本文引用的文献

2
Wound Healing Society 2015 update on guidelines for pressure ulcers.
Wound Repair Regen. 2016 Jan-Feb;24(1):145-62. doi: 10.1111/wrr.12396. Epub 2016 Mar 4.
3
Wound Healing Society 2015 update on guidelines for venous ulcers.
Wound Repair Regen. 2016 Jan-Feb;24(1):136-44. doi: 10.1111/wrr.12394.
4
WHS guidelines update: Diabetic foot ulcer treatment guidelines.
Wound Repair Regen. 2016 Jan-Feb;24(1):112-26. doi: 10.1111/wrr.12391.
5
What's new in wound treatment: a critical appraisal.
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:268-74. doi: 10.1002/dmrr.2747.
6
Debridement for venous leg ulcers.
Cochrane Database Syst Rev. 2015 Sep 14;2015(9):CD008599. doi: 10.1002/14651858.CD008599.pub2.
7
8
IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes.
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:75-83. doi: 10.1002/dmrr.2700.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验